1. Home
  2. GHLD vs CRGX Comparison

GHLD vs CRGX Comparison

Compare GHLD & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • CRGX
  • Stock Information
  • Founded
  • GHLD 1960
  • CRGX 2021
  • Country
  • GHLD United States
  • CRGX United States
  • Employees
  • GHLD 4200
  • CRGX N/A
  • Industry
  • GHLD Finance: Consumer Services
  • CRGX
  • Sector
  • GHLD Finance
  • CRGX
  • Exchange
  • GHLD Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • GHLD 831.7M
  • CRGX 964.5M
  • IPO Year
  • GHLD 2020
  • CRGX 2023
  • Fundamental
  • Price
  • GHLD $13.64
  • CRGX $13.58
  • Analyst Decision
  • GHLD Buy
  • CRGX Strong Buy
  • Analyst Count
  • GHLD 5
  • CRGX 6
  • Target Price
  • GHLD $16.30
  • CRGX $31.80
  • AVG Volume (30 Days)
  • GHLD 10.5K
  • CRGX 237.0K
  • Earning Date
  • GHLD 11-06-2024
  • CRGX 11-12-2024
  • Dividend Yield
  • GHLD 3.72%
  • CRGX N/A
  • EPS Growth
  • GHLD N/A
  • CRGX N/A
  • EPS
  • GHLD N/A
  • CRGX N/A
  • Revenue
  • GHLD $829,864,000.00
  • CRGX N/A
  • Revenue This Year
  • GHLD $37.55
  • CRGX N/A
  • Revenue Next Year
  • GHLD $29.77
  • CRGX N/A
  • P/E Ratio
  • GHLD N/A
  • CRGX N/A
  • Revenue Growth
  • GHLD 4.51
  • CRGX N/A
  • 52 Week Low
  • GHLD $12.78
  • CRGX $13.33
  • 52 Week High
  • GHLD $18.26
  • CRGX $33.92
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 40.27
  • CRGX 38.60
  • Support Level
  • GHLD $13.63
  • CRGX $13.33
  • Resistance Level
  • GHLD $13.98
  • CRGX $15.26
  • Average True Range (ATR)
  • GHLD 0.26
  • CRGX 1.22
  • MACD
  • GHLD 0.05
  • CRGX -0.17
  • Stochastic Oscillator
  • GHLD 26.03
  • CRGX 27.33

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Share on Social Networks: